47 studies found for:    Open Studies | "Helicobacter Infections"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Helicobacter Infections"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting The Efficacy of the 7 Days Tailored Therapy as the 1st Eradication of H. Pylori Infection
Condition: Helicobacter Infection
Interventions: Drug: 10 day sequential therapy (Esomeprazole, amoxicillin, clarithromycin, metronidazole);   Procedure: 7 day tailored therapy based on antimicrobial susceptibility testing;   Drug: PPI based triple therapy [Esomeprazole, amoxicillin, clarithromycin];   Drug: bismuth quadruple therapy [Esomeprazole, Tri potassium dicitrate bismuthate, Metronidazole, Tetracycline];   Drug: moxifloxacin triple therapy [Esomeprazole, Moxifloxacin, Amoxicillin]
2 Recruiting The Efficacy of the 7 Days Tailored Therapy as 2nd Rescue Therapy for Eradication of H. Pylori Infection
Condition: Helicobacter Infection
Interventions: Procedure: H. pylori culture and antimicrobial susceptibility testing;   Drug: 14 days empirical bismuth quadruple therapy (Proton pump inhibitor);   Drug: Metronidazole;   Drug: Tetracycline;   Drug: tripotassium dicitrate bismuthate;   Drug: 7 days tailored therapy Proton Pump Inhibitor;   Drug: Moxifloxacin;   Drug: Amoxicillin
3 Unknown  Standard Triple Therapy vs Sequential Therapy in Treatment of H Pylori Infection
Condition: Helicobacter Infection
Interventions: Drug: Standard Triple Therapy;   Drug: Sequential Therapy
4 Unknown  Comparison of 7-Day and 14-Day Bismuth Based Quadruple Therapy for Secondary Helicobacter Pylori Eradication
Condition: Helicobacter Infection
Interventions: Drug: pantoprazole;   Drug: bismuth;   Drug: metronidazole;   Drug: tetracycline
5 Recruiting Dual Therapy With High Doses of Ilaprazole and Amoxicillin for Helicobacter Pylori Infection
Condition: Helicobacter Infections
Intervention: Drug: Ilaprazole + Amoxicillin
6 Recruiting Efficacy and Safety of Basic Triple Therapy Including Ilaprazole on the First Line Eradication Treatment of H.Pylori
Condition: Helicobacter Infections
Interventions: Drug: Noltec tab. 10mg;   Drug: Chongkundang Amoxicillin Cap. 500mg;   Drug: Cravit Tab. 500mg
7 Not yet recruiting Endofaster Test for Helicobacter Pylori Detection in Patients on Proton Pump Inhibitor Therapy
Condition: Helicobacter Infections
Interventions: Procedure: Gastroscopy;   Device: EndoFaster test;   Other: Clo test;   Other: Faecal Helicobacter pylori antigen
8 Unknown  Treating H. Pylori in Parkinson's Patients With Motor Fluctuations
Conditions: Parkinson's Disease;   Helicobacter Infections;   Motor Fluctuations
Interventions: Drug: clartihromycin, amoxicillin, and omeprazole;   Drug: placebo
9 Unknown  Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) Infection
Conditions: Helicobacter Infections;   Gastritis;   Gastric Ulcer;   Duodenal Ulcer
Intervention: Drug: rabeprazole, amoxicillin, clarithromycin, metronidazole
10 Unknown  Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori
Conditions: Helicobacter Infections;   Gastritis;   Gastric Ulcer;   Duodenal Ulcer
Intervention: Drug: Lansoprazole, clarithromycin, amoxicillin
11 Unknown  Immediate Detection of Helicobacter Infection With a New Electrochemical System.
Condition: H. Pylori Infection
Interventions: Device: Electrochemical H. pylori detection method;   Device: IHC;   Device: C13-urea breath test;   Device: HUT
12 Recruiting Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for Rescue Treatment of Hp Infection
Condition: Helicobacter Pylori Infection
Interventions: Drug: High-dose dual therapy (rabeprazole, amoxicillin);   Drug: Bismuth-containing quadruple therapy (rabeprazole, tripotassium dicitrate bismuthate, metronidazole, tetracycline)
13 Recruiting Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for First-line Treatment of Hp Infection
Condition: Helicobacter Pylori Infection
Interventions: Drug: High-dose dual therapy (rabeprazole, amoxicillin);   Drug: Bismuth-containing quadruple therapy (rabeprazole, tripotassium dicitrate bismuthate, metronidazole, tetracycline)
14 Not yet recruiting The Effect of Miswak Chewing Sticks on the Oral Helicobacter Pylori Infection
Conditions: Caries;   Periodontitis
Intervention: Biological: Oral hygiene with Miswak
15 Recruiting Randomized Study on Efficacy of Gemifloxacin-based Regimen for Helicobacter Pylori Infection
Condition: Helicobacter Pylori Infection
Interventions: Drug: Gemifloxacin-based triple therapy;   Drug: Standard triple therapy
16 Not yet recruiting The Diagnostic Validity of the Urea Breath Test
Condition: Helicobacter Pylori Infection
Intervention: Drug: Citric acid
17 Recruiting Comparison of 12-day Reverse Hybrid Therapy and 12-day Standard Triple Therapy for Helicobacter Pylori Infection
Condition: Helicobacter Pylori Infection
Interventions: Drug: Reverse hybrid therapy;   Drug: Standard triple therapy
18 Recruiting Volatile Markers in Digestive Cancer
Conditions: Colorectal Cancer;   Colorectal Adenoma;   Gastric Cancer;   Peptic Ulcer Disease;   Atrophic Gastritis;   Intestinal Metaplasia;   H.Pylori Infection;   Normal Control;   Average-risk General Population
Interventions: Procedure: Breath sampling for volatile marker detection;   Procedure: Upper endoscopy with biopsies;   Procedure: Colonoscopy with biopsies or lesion removal when required;   Procedure: Plasma/serum sampling;   Procedure: Faecal sample acquisition;   Procedure: Histological evaluation of the surgery material
19 Recruiting European Registry on the Management of Helicobacter Pylori Infection
Condition: H. Pylori Infection
Intervention:
20 Recruiting Efficacy of Acetylcysteine-containing Triple Therapy in the First Line of Helicobacter Pylori Infection
Condition: Helicobacter Pylori Infection
Interventions: Drug: N-acetylcysteine + PPI-amoxicillin-clarithromycin;   Drug: PPI-amoxicillin-clarithromycin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years